REPL Replimune Group, Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 14, 2026
$13,07
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$1,5052-Wochen-Tief
$16,3352-Wochen-Hoch
Marktkapitalisierung (MRQ)
$1.10B
P/E
-3.9
EPS
$-3.38
Ihre Abzeichen
52W-Spanne
$2–$16
Analystenbewertung
BUY
Kursziel
$20
P/E
-3.9
ROE
-146.2%
Nettogewinnmarge
·
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
REPL Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$13.07
Marktkapitalisierung (MRQ)
$1.10B
P/E
-3.9
EPS
$-3.38
ROE
-146.2%
Verschuldungsgrad (MRQ)
0.8
52W-Spanne
$2–$16
REPL Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
EPS$-3.382021-03-31 → 2026-03-31
Freier Cashflow$-285M2020-03-31 → 2026-03-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | REPL | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E | -3.95-Jahres-Durchschnitt ≈-4.3 | ≈-4.3 | · | · | |
| K/B (MRQ) | 10.45-Jahres-Durchschnitt ≈2.1 | ≈2.1 | 4.2 | Überbewertet | |
| EV / EBITDA (TTM) | -3.45-Jahres-Durchschnitt ≈-1.4 | ≈-1.4 | · | · | |
| Kurs / FCF (TTM) | -3.95-Jahres-Durchschnitt ≈-5.2 | ≈-5.2 | · | · | |
| Kurs / Cashflow (TTM) | -3.95-Jahres-Durchschnitt ≈-5.3 | ≈-5.3 | · | · | |
| EV / FCF (TTM) | -3.55-Jahres-Durchschnitt ≈-1.8 | ≈-1.8 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 6.55-Jahres-Durchschnitt ≈2.1 | ≈2.1 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | REPL | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| ROA | -71.0%5-Jahres-Durchschnitt ≈-42.3% | ≈-42.3% | -44.4% | Schwach | |
| ROE | -146.2%5-Jahres-Durchschnitt ≈-62.7% | ≈-62.7% | -33.0% | Schwach | |
| ROIC | -128.0%5-Jahres-Durchschnitt ≈-67.8% | ≈-67.8% | -128.0% | Im Einklang |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | REPL | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital (MRQ) | 0.85-Jahres-Durchschnitt ≈0.2 | ≈0.2 | · | · | |
| Liquiditätsgrad (MRQ) | 5.25-Jahres-Durchschnitt ≈12.1 | ≈12.1 | 13.2 | Geringe Liquidität | |
| Quick Ratio | 4.65-Jahres-Durchschnitt ≈11.8 | ≈11.8 | 5.1 | Im Einklang | |
| Langfristige Schulden / Eigenkapital (MRQ) | 0.85-Jahres-Durchschnitt ≈0.2 | ≈0.2 | · | · |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-2.9%
Nächster Bericht
Nov 04, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 31. März 2027 | Aug 14, 2026 | $-0.72 | $-0.73 | 1.7% |
| 30. Juni 2026 | Aug 14, 2026 | $-0.72 | $-0.73 | 1.7% |
| 31. März 2026 | $-0.76 | $-0.73 | -4.5% | |
| 31. Dezember 2025 | $-0.77 | $-0.91 | 15.2% | |
| 30. September 2025 | $-0.90 | $-0.80 | -12.3% | |
| 30. Juni 2025 | $-0.95 | $-0.82 | -15.4% | |
| 31. März 2025 | $-0.82 | $-0.77 | -6.8% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $221M | $189M | $175M | $127M | $80M | $57M | $39M | $22M | $14M | |
| SG&A Expense | $99M | $72M | $60M | $51M | $39M | $23M | $17M | $9M | $6M | |
| Operating Expenses | $320M | $262M | $235M | $177M | $118M | $80M | $56M | $31M | $19M | |
| Operating Income | $-320M | $-262M | $-235M | $-177M | $-118M | $-80M | $-56M | $-31M | $-19M | |
| Other Non-op | $-942.0K | $-202.0K | $771.0K | $-6M | $-1M | $-665.0K | $-16.0K | $451.0K | $-2M | |
| Pretax Income | $-314M | $-247M | $-215M | $-174M | $-118M | $-81M | $-53M | $-31M | $-20M | |
| Income Tax | $-551.0K | $468.0K | $408.0K | $288.0K | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-314M | $-247M | $-216M | $-174M | $-118M | $-81M | $-53M | $-31M | $-20M | |
| EPS (Basic) | $-3.38 | $-3.07 | $-3.24 | $-2.99 | $-2.26 | $-1.75 | · | · | · | |
| EPS (Diluted) | $-3.38 | $-3.07 | $-3.24 | $-2.99 | $-2.26 | $-1.75 | · | · | · | |
| Shares (Basic) | 92,803,711 | 80,564,147 | 66,569,894 | 58,213,010 | 52,212,269 | 46,248,969 | · | · | · | |
| Shares (Diluted) | 92,803,711 | 80,564,147 | 66,569,894 | 58,213,010 | 52,212,269 | 46,248,969 | · | · | · | |
| EBITDA | $-317M | $-258M | $-232M | $-175M | $-116M | $-78M | $-56M | · | · |
Bilanz
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $209M | $111M | $74M | $147M | $106M | $183M | $60M | $26M | $18M | |
| Short-term Investments | $60M | $373M | $346M | $437M | $290M | $294M | $109M | $109M | $44M | |
| Prepaid Expense | $9M | $8M | $8M | $6M | $5M | $4M | $3M | $4M | $763.0K | |
| Current Assets | $279M | $496M | $434M | $593M | $404M | $484M | $174M | $141M | $65M | |
| PP&E (Net) | $13M | $14M | $10M | $7M | $8M | $7M | $7M | $12M | $370.0K | |
| PP&E (Gross) | $30M | $27M | $20M | $15M | $13M | $10M | $8M | $13M | $626.0K | |
| Accum. Depreciation | $17M | $13M | $10M | $7M | $5M | $3M | $937.0K | $404.0K | $256.0K | |
| Other Non-current Assets | $3M | $1M | $0 | · | · | · | · | · | · | |
| Total Assets | $332M | $551M | $488M | $647M | $461M | $543M | $234M | $154M | $65M | |
| Accounts Payable | $7M | $12M | $3M | $5M | $4M | $2M | $3M | $7M | $2M | |
| Current Liabilities | $58M | $62M | $40M | $34M | $21M | $15M | $12M | $10M | $5M | |
| Capital Leases | $2M | $3M | $4M | $4M | $5M | $5M | $4M | · | · | |
| Other Non-current Liabilities | $455.0K | $941.0K | $786.0K | $472.0K | $0 | · | · | · | · | |
| Total Liabilities | $166M | $135M | $113M | $91M | $50M | $44M | $50M | $16M | $7M | |
| Long-term Debt | · | · | · | $29M | $0 | · | $10M | · | · | |
| Total Debt | $83M | $46M | $45M | $29M | · | · | · | · | · | |
| Common Stock | $82.0K | $77.0K | $61.0K | $57.0K | $47.0K | $47.0K | $37.0K | $32.0K | $5.0K | |
| Paid-in Capital | $1.42B | $1.36B | $1.07B | $1.03B | $723M | $692M | $297M | $199M | $1M | |
| Retained Earnings | $-1.26B | $-949M | $-701M | $-485M | $-311M | $-193M | $-112M | $-60M | $-29M | |
| AOCI | $5M | $5M | $5M | $6M | $-973.0K | $-394.0K | $-982.0K | $-1M | $-238.0K | |
| Stockholders' Equity | $166M | $416M | $375M | $555M | $411M | $499M | $184M | $138M | $-28M | |
| Liabilities + Equity | $332M | $551M | $488M | $647M | $461M | $543M | $234M | $154M | $65M | |
| Shares Outstanding | 82,716,923 | 77,085,024 | 61,415,105 | 56,676,313 | 47,338,660 | 46,566,481 | 36,668,743 | 31,656,950 | 5,007,485 |
Cashflow
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $4M | $3M | $2M | $2M | $2M | $533.0K | $148.0K | $109.0K | |
| Stock-based Comp | $32M | $35M | $34M | $28M | $24M | $12M | $8M | $3M | $812.0K | |
| Other Non-cash | $-2M | $17M | $-6M | $16M | $9M | $6M | $-16M | · | · | |
| Operating Cash Flow | $-280M | $-192M | $-185M | $-128M | $-82M | $-61M | $-61M | $-25M | $-16M | |
| CapEx | $4M | $7M | $6M | $2M | $2M | $2M | $7M | $3M | $136.0K | |
| Investing Cash Flow | $311M | $-24M | $97M | $-143M | $-2M | $-189M | $-5M | $-66M | $-44M | |
| Debt Issued | $35M | $0 | $15M | $28M | $0 | · | $10M | · | · | |
| Net Debt Issued | $35M | $0 | $15M | $28M | $0 | $-10M | $10M | · | · | |
| Stock Issued | · | $156M | $0 | $150M | $0 | $286M | · | · | · | |
| Net Stock Activity | · | $156M | $0 | $150M | $0 | · | · | · | · | |
| Financing Cash Flow | $66M | $252M | $16M | $311M | $7M | $372M | $100M | $101M | $55M | |
| Net Change in Cash | $98M | $37M | $-72M | $41M | $-77M | $123M | $34M | $9M | $-3M | |
| Taxes Paid | $-5.0K | $105.0K | $300.0K | $0 | $55.0K | $0 | · | · | · | |
| Free Cash Flow | $-285M | $-199M | $-191M | $-130M | $-85M | $-64M | $-67M | · | · |
Rentabilität
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -71.0% | -47.6% | -38.0% | -31.5% | -23.5% | -20.8% | -27.1% | · | · | |
| ROE | -146.2% | -55.1% | -54.2% | -30.3% | -27.8% | -15.9% | -27.6% | · | · | |
| ROIC | -128.0% | -56.7% | -56.1% | -30.4% | · | -16.0% | -30.6% | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.8 | 8.0 | 10.7 | 17.5 | 19.5 | 33.3 | 14.7 | · | · | |
| Quick Ratio | 4.6 | 7.8 | 10.4 | 17.2 | 19.1 | 32.7 | 14.2 | · | · | |
| Debt / Equity | 0.5 | 0.1 | 0.1 | 0.1 | · | · | · | · | · | |
| LT Debt / Equity | 0.5 | 0.1 | 0.1 | 0.1 | · | · | · | · | · |
Pro Aktie
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.01 | $5.39 | $6.10 | $9.80 | $8.69 | $10.71 | $5.01 | · | · | |
| Cash Flow / Share | $-3.02 | $-2.39 | $-2.79 | $-2.20 | $-1.57 | · | · | · | · | |
| Cash / Share | $2.53 | $1.44 | $1.21 | $2.59 | $2.24 | $3.92 | $1.62 | · | · | |
| Dividend / Share | · | · | · | · | · | · | · | $0.00 | · | |
| EPS (TTM) | $-3.38 | $-3.07 | $-3.24 | $-2.99 | $-2.26 | $-1.75 | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-314M | $-247M | $-216M | $-174M | $-118M | $-81M | $-53M | $-31M | · | |
| Market Cap | $633M | $752M | $502M | $1.00B | $804M | $1.42B | $366M | · | · | |
| Enterprise Value | $447M | $314M | $126M | $446M | · | · | · | · | · | |
| P/E | -2.3 | -3.2 | -2.5 | -5.9 | -7.5 | -17.4 | · | · | · | |
| P/B | 3.8 | 1.8 | 1.3 | 1.8 | 2.0 | 2.8 | 2.0 | · | · | |
| P / Tangible Book | 3.8 | 1.8 | 1.3 | 1.8 | 2.0 | 2.8 | · | · | · | |
| P / Cash Flow | -2.3 | -3.9 | -2.7 | -7.8 | -9.8 | -23.1 | -6.0 | · | · | |
| P / FCF | -2.2 | -3.8 | -2.6 | -7.7 | -9.5 | -22.3 | -5.4 | · | · | |
| EV / EBITDA | -1.4 | -1.2 | -0.5 | -2.6 | · | · | · | · | · | |
| EV / FCF | -1.6 | -1.6 | -0.7 | -3.4 | · | · | · | · | · | |
| Earnings Yield | -44.2% | -31.5% | -39.7% | -16.9% | -13.3% | -5.7% | · | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2024 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $49M | $52M | $53M | $58M | $58M | $55M | $48M | $43M | $43M | $43M | $40M | $38M | $30M | $29M | |
| SG&A Expense | $19M | $21M | $19M | $26M | $33M | $24M | $18M | $15M | $14M | $14M | $15M | $15M | $11M | $13M | |
| Operating Expenses | $68M | $73M | $72M | $84M | $90M | $79M | $66M | $59M | $57M | $57M | $56M | $53M | $42M | $42M | |
| Operating Income | $-68M | $-73M | $-72M | $-84M | $-90M | $-79M | $-66M | $-59M | $-57M | $-57M | $-56M | $-53M | $-42M | $-42M | |
| Other Non-op | $-688.0K | $-77.0K | $-580.0K | $-876.0K | $591.0K | $645.0K | $-3M | $2M | $406.0K | $1M | $1M | $-1M | $147.0K | $-3M | |
| Pretax Income | · | $-73M | $-71M | · | · | $-74M | $-66M | $-53M | $-54M | $-51M | $-49M | $-49M | $-40M | $-43M | |
| Income Tax | · | $-240.0K | $-311.0K | $0 | $0 | $-107.0K | $575.0K | $0 | $0 | $473.0K | $201.0K | $288.0K | $0 | $0 | |
| Net Income | $-70M | $-73M | $-71M | $-83M | $-87M | $-74M | $-66M | $-53M | $-54M | $-51M | $-50M | $-39M | $-40M | $-43M | |
| EPS (Basic) | $-0.72 | $-0.76 | $-0.77 | $-0.90 | $-0.95 | $-0.82 | $-0.79 | $-0.68 | $-0.78 | $-0.77 | $-0.75 | $-0.73 | $-0.69 | $-0.79 | |
| EPS (Diluted) | $-0.72 | $-0.76 | $-0.77 | $-0.90 | $-0.95 | $-0.82 | $-0.79 | $-0.68 | $-0.78 | $-0.77 | $-0.75 | $-0.73 | $-0.69 | $-0.79 | |
| Shares (Basic) | 96,864,452 | · | 92,187,581 | 91,915,769 | 91,516,199 | · | 83,498,892 | 78,570,135 | 69,185,885 | 66,645,691 | 66,367,702 | · | 57,857,132 | 54,770,291 | |
| Shares (Diluted) | 96,864,452 | · | 92,187,581 | 91,915,769 | 91,516,199 | · | 83,498,892 | 78,570,135 | 69,185,885 | 66,645,691 | 66,367,702 | · | 57,857,132 | 54,770,291 | |
| EBITDA | $-67M | · | $-71M | $-83M | $-90M | · | $-65M | $-58M | $-57M | $-57M | $-55M | · | $-42M | $-42M |
Bilanz
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2024 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $185M | $209M | $123M | $102M | $97M | $111M | $172M | $113M | $152M | $98M | $106M | $147M | $207M | $89M | |
| Short-term Investments | $10M | $60M | $146M | $221M | $306M | $373M | $364M | $319M | $317M | $369M | $433M | $437M | $410M | $283M | |
| Prepaid Expense | $5M | $9M | $8M | $8M | $8M | $8M | $8M | $9M | $6M | $9M | $8M | $6M | $6M | $5M | |
| Current Assets | $201M | $279M | $280M | $334M | $413M | $496M | $548M | $443M | $480M | $479M | $550M | $593M | $624M | $379M | |
| PP&E (Net) | $12M | $13M | $14M | $15M | $15M | $14M | $14M | $13M | $11M | $9M | $8M | $7M | $8M | $8M | |
| PP&E (Gross) | $30M | $30M | $30M | $30M | $29M | $27M | $26M | $24M | $22M | $19M | $15M | $15M | $14M | $14M | |
| Accum. Depreciation | $18M | $17M | $16M | $15M | $14M | $13M | $13M | $12M | $11M | $9M | $8M | $7M | $7M | $6M | |
| Other Non-current Assets | $3M | $3M | $1M | $1M | $1M | $1M | $1M | · | · | · | · | · | · | · | |
| Total Assets | $252M | $332M | $334M | $389M | $470M | $551M | $604M | $498M | $535M | $533M | $604M | $647M | $679M | $436M | |
| Accounts Payable | $4M | $7M | $6M | $6M | $15M | $12M | $7M | $8M | $864.0K | $4M | $5M | $5M | $4M | $4M | |
| Current Liabilities | $38M | $58M | $50M | $53M | $60M | $62M | $48M | $44M | $36M | $39M | $32M | $34M | $26M | $24M | |
| Capital Leases | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | |
| Other Non-current Liabilities | $455.0K | $455.0K | $693.0K | $941.0K | $941.0K | $941.0K | $1M | $786.0K | $786.0K | $793.0K | $578.0K | $472.0K | · | · | |
| Total Liabilities | $147M | $166M | $123M | $126M | $133M | $135M | $121M | $117M | $109M | $111M | $90M | $91M | $83M | $52M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | $44M | $29M | · | $28M | · | |
| Total Debt | $84M | · | $48M | $47M | $47M | · | $46M | · | · | · | · | · | · | · | |
| Common Stock | $84.0K | $82.0K | $79.0K | $78.0K | $78.0K | $77.0K | $77.0K | $68.0K | $68.0K | $61.0K | $57.0K | $57.0K | $57.0K | $50.0K | |
| Paid-in Capital | $1.43B | $1.42B | $1.39B | $1.38B | $1.37B | $1.36B | $1.35B | $1.19B | $1.18B | $1.06B | $1.05B | $1.03B | $1.03B | $778M | |
| Retained Earnings | $-1.33B | $-1.26B | $-1.19B | $-1.12B | $-1.04B | $-949M | $-874M | $-808M | $-755M | $-646M | $-535M | $-485M | $-436M | $-397M | |
| AOCI | $6M | $5M | $6M | $5M | $4M | $5M | $6M | $4M | $4M | $5M | $4M | $6M | $4M | $3M | |
| Stockholders' Equity | $106M | $166M | $211M | $263M | $337M | $416M | $482M | $381M | $426M | $422M | $514M | $555M | $595M | $384M | |
| Liabilities + Equity | $252M | $332M | $334M | $389M | $470M | $551M | $604M | $498M | $535M | $533M | $604M | $647M | $679M | $436M | |
| Shares Outstanding | 83,979,366 | 82,716,923 | 79,631,167 | 78,403,255 | 77,807,174 | 77,085,024 | 77,009,058 | 68,394,588 | 68,309,968 | 61,387,786 | 58,976,325 | 56,676,313 | 56,632,999 | 49,739,407 |
Cashflow
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2024 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $937.0K | $859.0K | $800.0K | $800.0K | $873.0K | $866.0K | $1M | $900.0K | $736.0K | $700.0K | $621.0K | $528.0K | $682.0K | $617.0K | |
| Stock-based Comp | $8M | $8M | $7M | $8M | $9M | $8M | $9M | $9M | $9M | $8M | $9M | $7M | $7M | $7M | |
| Other Non-cash | $-15M | · | · | · | $42.0K | · | · | · | $-6M | · | $-8M | · | · | · | |
| Operating Cash Flow | $-76M | $-56M | $-66M | $-81M | $-77M | $-54M | $-51M | $-39M | $-49M | $-47M | $-49M | $-33M | $-29M | $-33M | |
| CapEx | $6.0K | $5.0K | $135.0K | $1M | $3M | $1M | $2M | $2M | $2M | $2M | $449.0K | $251.0K | $555.0K | $396.0K | |
| Investing Cash Flow | $50M | $87M | $75M | $84M | $65M | $-8M | $-46M | $458.0K | $30M | $54M | $7M | $-23M | $-125M | $36.0K | |
| Debt Issued | · | · | · | · | · | $0 | · | · | · | · | · | $-2M | · | · | |
| Stock Issued | · | · | · | $0 | $0 | $-1.0K | $108M | $0 | $48M | $-48M | $0 | $105M | $7M | $7M | |
| Net Stock Activity | · | · | · | · | $0 | · | · | · | $48M | · | · | · | $7M | $7M | |
| Financing Cash Flow | $800.0K | $56M | $10M | $324.0K | $-158.0K | $-132.0K | $156M | $-39.0K | $97M | $15M | $1M | $-77.0K | $271M | $7M | |
| Net Change in Cash | $-24M | $86M | $21M | $5M | $-14M | $-61M | $59M | $-38M | $77M | $22M | $-40M | $-60M | $118M | $-23M | |
| Taxes Paid | $33.0K | $-130.0K | · | · | $0 | $0 | · | · | · | $300.0K | · | · | · | · | |
| Free Cash Flow | $-76M | · | · | · | $-80M | · | · | · | $-51M | · | $-49M | · | · | · |
Rentabilität
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2024 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -19.3% | · | -15.1% | -18.7% | -17.3% | · | -11.7% | · | · | -8.4% | -9.3% | · | -6.8% | -9.2% | |
| ROE | -31.5% | · | -20.5% | -25.8% | -22.7% | · | -14.7% | · | · | -10.1% | -10.7% | · | -7.7% | -10.2% | |
| ROIC | · | · | -27.7% | · | · | · | -12.6% | · | · | -13.5% | -10.9% | · | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2024 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.2 | · | 5.6 | 6.3 | 6.9 | · | 11.4 | · | · | 12.4 | 17.1 | · | 23.6 | 16.1 | |
| Quick Ratio | 5.1 | · | 5.4 | 6.1 | 6.8 | · | 11.2 | · | · | 12.1 | 16.7 | · | 23.3 | 15.8 | |
| Debt / Equity | 0.8 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.8 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | · | · | · | · | · | · | · |
Pro Aktie
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2024 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.26 | · | $2.64 | $3.36 | $4.33 | · | $6.26 | · | · | $6.87 | $8.72 | · | $10.51 | $7.72 | |
| Cash Flow / Share | $-0.78 | · | · | · | $-0.84 | · | · | · | $-0.71 | · | $-0.73 | · | · | · | |
| Cash / Share | $2.21 | · | $1.54 | $1.30 | $1.25 | · | $2.24 | · | · | $1.59 | $1.81 | · | $3.65 | $1.79 | |
| EPS (TTM) | $-3.15 | · | $-3.44 | $-3.46 | $-3.24 | · | · | · | · | · | · | · | $-2.86 | $-2.74 |
Bewertung (TTM)
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2024 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-297M | · | $-315M | $-310M | $-280M | · | · | · | · | · | · | · | $-157M | $-147M | |
| Market Cap | $930M | · | $774M | $329M | $723M | · | $933M | · | · | $517M | $1.37B | · | $1.54B | $859M | |
| Enterprise Value | $818M | · | $553M | $52M | $366M | · | $442M | · | · | · | · | · | · | · | |
| P/E | -3.5 | · | -2.8 | -1.2 | -2.9 | · | · | · | · | · | · | · | -9.5 | -6.3 | |
| P/B | 8.8 | · | 3.7 | 1.2 | 2.1 | · | 1.9 | · | · | 1.2 | 2.7 | · | 2.6 | 2.2 | |
| P / Tangible Book | 8.8 | · | 3.7 | 1.2 | 2.1 | · | 1.9 | · | · | 1.2 | 2.7 | · | 2.6 | 2.2 | |
| P / Cash Flow | -12.3 | · | · | · | -9.4 | · | · | · | · | · | -28.2 | · | · | · | |
| Earnings Yield | -28.5% | · | -35.4% | -82.6% | -34.9% | · | · | · | · | · | · | · | -10.5% | -15.9% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Nettoergebnis | $-314M | $-247M | $-216M | $-174M | $-118M |
| Verwässerte EPS | $-3.38 | $-3.07 | $-3.24 | $-2.99 | $-2.26 |
| Kennzahl | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.5 | 0.1 | 0.1 | 0.1 | · |
| Liquiditätsgrad | 4.8 | 8.0 | 10.7 | 17.5 | 19.5 |
| Quick Ratio | 4.6 | 7.8 | 10.4 | 17.2 | 19.1 |
| Kennzahl | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-285M | $-199M | $-191M | $-130M | $-85M |
Institutionelle Eigentümer (13F) 235 Einreicher · $1.2B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
235
Gehaltener Wert
$1.2B
Neue Positionen
80
Geschlossene Positionen
53
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 80 (+25 vs. Vorquartal) | 53 (+27 vs. Vorquartal) | 85 (+18 vs. Vorquartal) | 46 (-11 vs. Vorquartal) | +16.3M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | $122.271.870 | 11.045.336 | 10,47% | Aktien |
| BlackRock, Inc. | $99.170.982 | 8.958.535 | 8,49% | Aktien |
| RTW INVESTMENTS, LP | $82.046.202 | 7.411.581 | 7,02% | Aktien |
| Ridgeback Capital Investments L.P. | $80.928.962 | 7.310.656 | 6,93% | Aktien |
| GOLDMAN SACHS GROUP INC | $50.269.070 | 4.541.018 | 4,30% | Aktien |
| STATE STREET CORP | $49.152.394 | 4.440.144 | 4,21% | Aktien |
| MONTANOVA CAPITAL, LLC | $48.595.485 | 4.389.836 | 4,16% | Aktien |
| Boxer Capital Management, LLC | $44.091.810 | 3.983.000 | 3,77% | Aktien |
| VANGUARD GROUP INC | $36.704.645 | 3.776.198 | 3,14% | Aktien |
| Caption Management, LLC | $32.687.496 | 2.952.800 | 2,80% | Kaufoption |
| VANGUARD CAPITAL MANAGEMENT LLC | $32.058.764 | 2.896.004 | 2,74% | Aktien |
| FCPM III SERVICES B.V. | $31.088.634 | 2.808.368 | 2,66% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $28.408.287 | 2.566.241 | 2,43% | Aktien |
| Logos Global Management LP | $27.675.000 | 2.500.000 | 2,37% | Aktien |
| JANE STREET GROUP, LLC | $25.710.573 | 2.322.545 | 2,20% | Aktien |
| Erste Asset Management GmbH | $23.744.000 | 2.120.000 | 2,03% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $22.534.696 | 2.035.187 | 1,93% | Aktien |
| D. E. Shaw & Co., Inc. | $19.814.901 | 1.789.964 | 1,70% | Aktien |
| Opaleye Management Inc. | $15.331.873 | 1.384.993 | 1,31% | Aktien |
| TORONTO DOMINION BANK | $14.114.250 | 1.275.000 | 1,21% | Aktien |
| UBS Group AG | $12.490.015 | 1.128.276 | 1,07% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $12.216.852 | 1.103.600 | 1,05% | Kaufoption |
| Artisan Partners Limited Partnership | $10.776.601 | 973.496 | 0,92% | Aktien |
| FMR LLC | $10.288.181 | 929.375 | 0,88% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $9.099.075 | 821.958 | 0,78% | Aktien |
| CITADEL ADVISORS LLC | $8.681.459 | 784.233 | 0,74% | Aktien |
| Caption Management, LLC | $8.677.474 | 783.873 | 0,74% | Aktien |
| Invesco Ltd. | $8.017.381 | 724.244 | 0,69% | Aktien |
| Point72 Asset Management, L.P. | $8.006.510 | 723.262 | 0,69% | Aktien |
| DIADEMA PARTNERS LP | $7.708.041 | 696.300 | 0,66% | Kaufoption |
| MORGAN STANLEY | $7.671.553 | 693.003 | 0,66% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $7.547.039 | 681.756 | 0,65% | Aktien |
| CITADEL ADVISORS LLC | $7.501.032 | 677.600 | 0,64% | Kaufoption |
| Nuveen, LLC | $7.500.191 | 677.524 | 0,64% | Aktien |
| NORTHERN TRUST CORP | $7.368.391 | 665.618 | 0,63% | Aktien |
| ADAR1 Capital Management, LLC | $7.259.529 | 655.784 | 0,62% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $7.084.645 | 639.986 | 0,61% | Aktien |
| Eversept Partners, LP | $6.534.090 | 590.252 | 0,56% | Aktien |
| Susquehanna Portfolio Strategies, LLC | $6.034.357 | 545.109 | 0,52% | Aktien |
| DIADEMA PARTNERS LP | $5.562.675 | 502.500 | 0,48% | Verkaufsoption |
| DIMENSIONAL FUND ADVISORS LP | $5.559.490 | 502.130 | 0,48% | Aktien |
| Jefferies Financial Group Inc. | $5.484.798 | 495.465 | 0,47% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $5.415.333 | 489.190 | 0,46% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5.331.312 | 481.600 | 0,46% | Verkaufsoption |
| CITADEL ADVISORS LLC | $5.163.048 | 466.400 | 0,44% | Verkaufsoption |
| BANK OF AMERICA CORP /DE/ | $3.646.292 | 329.385 | 0,31% | Aktien |
| BARCLAYS PLC | $3.497.013 | 315.900 | 0,30% | Kaufoption |
| CITIGROUP INC | $3.321.000 | 300.000 | 0,28% | Verkaufsoption |
| READYSTATE ASSET MANAGEMENT LP | $3.320.535 | 299.958 | 0,28% | Aktien |
| ARMISTICE CAPITAL, LLC | $2.922.480 | 264.000 | 0,25% | Aktien |
Aktivisten & 5%+-Eigentümer 2 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Julian C. Baker, Felix J. Baker ×2 Einreichungen | 11. August 2026 | 11,80% | Änderung | Kapitalstruktur | SEC |
| ATLAS VENTURE FUND X, L.P., ATLAS VENTURE ASSOCIATES X, L.P., Atlas Venture Associates X, LLC, Atlas Venture Opportunity Fund I, L.P., Atlas Venture Associates Opportunity I, L.P., Atlas Venture Associates Opportunity I, LLC ×6 Einreichungen | 6. Dezember 2022 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 26 Insider · 8 Führungskräfte · 12 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Emily Luisa Hill | Chief Financial Officer | 17. August 2026 S | 215.852 | 0 | 3 | $-320.342 |
| Jean M. Franchi | Chief Financial Officer | 16. Mai 2023 S | 128.748 | 0 | 0 | $0 |
| Colin Love | Chief Operating Officer | 16. Mai 2024 S | 777.345 | 0 | 0 | $0 |
| Pamela Esposito | Chief Business Officer | 12. September 2023 M | 263.436 | 0 | 0 | $0 |
| Tanya Lewis | Chief Dev. Op. Officer | 13. Juni 2023 S | 135.293 | 0 | 0 | $0 |
| Andrea Pirzkall | Chief Medical Officer | 1. April 2021 A | 21.500 | 0 | 0 | $0 |
| Stephen A Gorgol | Chief Accounting Officer | 1. April 2020 A | · | 0 | 0 | $0 |
| Howard Kaufman | Chief Medical Officer | 26. November 2019 M | 58.067 | 0 | 0 | $0 |
| Philip Astley-Sparke | Direktor | 20. August 2026 G | 1.362.414 | 0 | 1 | $-89.698 |
| Veleka Peeples-Dyer | Direktor | 1. April 2026 A | · | 0 | 0 | $0 |
| Christy J. Oliger | Direktor | 1. April 2026 A | · | 0 | 0 | $0 |
| Dieter Weinand | Direktor | 1. April 2026 A | · | 0 | 0 | $0 |
| Madhavan Balachandran | Direktor | 1. April 2026 A | · | 0 | 0 | $0 |
| Kapil Dhingra | Direktor | 1. April 2026 A | 0 | 0 | 1 | $-32.958 |
| Paolo Pucci | Direktor | 1. April 2026 A | · | 0 | 0 | $0 |
| Joseph P Slattery | Direktor | 1. April 2026 A | 6.667 | 0 | 0 | $0 |
| Robert Coffin | Direktor | 16. Mai 2024 S | 1.821.872 | 0 | 0 | $0 |
| Hyam Levitsky | Direktor | 1. April 2024 A | · | 0 | 0 | $0 |
| Hugo Alexander Slootweg | Direktor | 1. April 2023 A | 4.721.449 | 0 | 0 | $0 |
| Jason P Rhodes | Direktor | 1. April 2022 A | 946.000 | 0 | 0 | $0 |
| Atlas Venture Fund X, L.P. | 10%-Eigentümer | 15. September 2020 J | 2.486.296 | 0 | 0 | $0 |
| Forbion Capital Fund III Cooperatief U.A. | 10%-Eigentümer | 24. Juli 2018 C | 4.721.449 | 0 | 0 | $0 |
| Andrew Schwendenman | · | 10. August 2026 S | 99.425 | 0 | 2 | $-139.089 |
| Konstantinos Xynos | · | 10. August 2026 S | 224.215 | 0 | 3 | $-285.662 |
| Sushil Patel | · | 10. August 2026 S | 708.151 | 0 | 3 | $-811.159 |
| Christopher Sarchi | · | 1. Juni 2026 S | 180.962 | 0 | 4 | $-254.158 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 25 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| PTH · Invesco Exchange-Traded Fund Trust | 2,17% | 603.368 SH | 1. Oktober 2026 | Täglich |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,91% | 279.000 SH | 1. Oktober 2026 | Täglich |
| BBC · ETFis Series Trust I | 0,85% | 35.001 NS | 31. Juli 2026 | N-PORT |
| IWC · iShares Trust | 0,25% | 269.214 SH | 11. September 2026 | Täglich |
| LABU · Direxion Shares ETF Trust | 0,21% | 93.330 NS | 31. Juli 2026 | N-PORT |
| IBB · iShares Trust | 0,09% | 667.135 SH | 11. September 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,08% | 6.672 SH | 1. Oktober 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,08% | 157.279 SH | 1. Oktober 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,06% | 68.718 SH | 19. August 2026 | Täglich |
| PWS · Pacer Funds Trust | 0,06% | 1.275 NS | 31. Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,03% | 2.035.119 SH | 11. September 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,03% | 455.775 SH | 19. August 2026 | Täglich |
| RSSL · Global X Funds | 0,03% | 37.835 NS | 31. Juli 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,01% | 178.058 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 861.771 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,01% | 150.898 SH | 19. August 2026 | Täglich |
| DFAC · Dimensional ETF Trust | 0,00% | 101.844 NS | 31. Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 113.006 SH | 11. September 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 23.178 SH | 11. September 2026 | Täglich |
| DCOR · Dimensional ETF Trust | 0,00% | 3.200 NS | 31. Juli 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 6.779 NS | 31. Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 691 NS | 31. Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.972.684 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 6.365 SH | 19. August 2026 | Täglich |
| IWN · iShares Trust | · | 742.716 SH | 11. September 2026 | Täglich |
REPL Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 14 Analysten
KAUF
Median-Ziel
$19.50
+49,2%
5 35,7%
Starker Kauf
7 50,0%
Kauf
1 7,1%
Halten
1 7,1%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
6 Analysten · 2026-09-28Mittelwert-Ziel $19.50 +49,2%
← Unter allen Zielen
Aktueller Preis $13.07
Tief$14.00
Mittelwert$19.50
Hoch$24.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| REPL | $633M | -2.3 | · | · | -146.2% | · |
| KLRA | · | · | · | · | · | · |
| ORIC | $806M | -5.6 | · | · | -36.5% | · |
| DMRA | · | · | 38.3% | -17981.1% | -167.0% | · |
| MNKD | $1.75B | 283.5 | 22.2% | 1.7% | -11.1% | · |
| TRAX | · | · | · | · | · | · |
| BCAX | $953M | -6.7 | · | · | -33.0% | · |
| VOR | $506M | -0.2 | · | · | 83.4% | · |
| MGTX | $645M | -5.6 | 144.6% | -140.3% | 8062.2% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 14, 2026